AACR 2022 | Cell expansion and vector design in novel T-cell therapies
Sid P. Kerkar
• 11 Apr 2022
Sid P. Kerkar, MD, Exuma Biotech, West Palm Beach, FL, briefly discusses the science behind cell expansion and vector design in the development of novel T-cell therapies. Dr Kerkar explains how high-throughput screening is used to find novel genes and factors that can cause T- and natural killer (NK)-like cells to proliferate, and the importance of future research in this area. This interview took place at the American Association for Cancer Research Annual Meeting in New Orleans, LA.
Disclosures
VP of R&D at Exuma Biotech
